Frontiers Myeloproliferative neoplasms – blurring the lines

Myeloproliferative Neoplasm (MPN) is a group of chronic blood cancers that arise from a hematopoietic stem cell (HSC) clone with somatic mutations causing co

Automated diagnostic support system with deep learning algorithms for distinction of Philadelphia chromosome-negative myeloproliferative neoplasms using peripheral blood specimen

Frontiers Successes and challenges in modeling heterogeneous BRAFV600E mutated central nervous system neoplasms

Novel Treatment Strategies for Myeloproliferative Neoplasms

Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia. - Abstract - Europe PMC

Do We Know Jack About JAK? A Closer Look at JAK/STAT Signaling

The myeloproliferative neoplasms, unclassifiable: clinical and pathological considerations

Targeting megakaryocytic-induced fibrosis in myeloproliferative

myeloproliferative neoplasm - List of Frontiers' open access articles

Myeloproliferative disorders: Pathology review: Video

Emergence of a Multiplicity of Time Scales in the Modelling of Climate, Matter, Life, and Economy

Aspirin responsive platelet thrombophilia in essential thrombocythemia and polycythemia vera

Arterial thrombosis in Philadelphia-negative myeloproliferative neoplasms predicts second cancer: a case-control study - ScienceDirect

Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN) Overlap Syndromes: Molecular Pathogenetic Mechanisms and Their Implications